Early studies have demonstrated that PAEs, as prototypical environmental endocrine-disrupting chemicals (EDCs), can contribute to breast carcinogenesis by simulating estrogens to bind to estrogen receptors (ER) [20] and then regulating the estrogen-responsive gene expression [21]. Here, ESR1 is linked to medical procedure.